Singapore markets close in 2 hours 35 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.76-0.27 (-3.36%)
At close: 4:00PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Cash flows from operating activities
Net income
-141,709
-166,411
-119,359
-96,968
-88,206
Depreciation & amortisation
4,375
4,628
5,516
4,997
3,469
Deferred income taxes
-
0
-260.818
0
-150.027
Stock-based compensation
23,226
15,648
10,901
10,655
13,071
Change in working capital
-84,185
-71,072
-3,543
4,709
2,896
Accounts receivable
-9,856
-17,015
2,023
2,435
10,080
Accounts payable
14,002
3,251
-4,586
601.256
2,684
Other working capital
-258,464
-179,500
-98,838
-75,635
-73,503
Other non-cash items
1,549
4,078
5,231
-360.795
-806.819
Net cash provided by operating activities
-256,701
-177,979
-97,850
-73,550
-63,209
Cash flows from investing activities
Investments in property, plant and equipment
-1,763
-1,521
-987.926
-2,085
-10,294
Acquisitions, net
-
-1,400
-
-
-
Purchases of investments
-325,376
-156,217
-100,950
-88,155
-95,700
Sales/maturities of investments
139,128
103,116
92,893
132,660
77,163
Other investing activities
-
-2,775
-
-
-
Net cash used for investing activities
-189,410
-58,796
-9,045
42,420
-27,831
Cash flows from financing activities
Common stock issued
286,631
454,486
9,089
29,228
94,348
Other financing activities
-5,867
-1,648
-1,135
-
-
Net cash used provided by (used for) financing activities
289,589
465,280
105,398
31,037
95,690
Net change in cash
-156,507
228,532
-1,498
-92.946
4,650
Cash at beginning of period
215,433
22,196
23,694
23,787
19,136
Cash at end of period
58,910
250,728
22,196
23,694
23,787
Free cash flow
Operating cash flow
-256,701
-177,979
-97,850
-73,550
-63,209
Capital expenditure
-1,763
-1,521
-987.926
-2,085
-10,294
Free cash flow
-258,464
-179,500
-98,838
-75,635
-73,503